← Back to Search

Decision Aid

Shared Decision Making Aid for Opioid Use Disorder

Barnes Jewish Hospital, Saint Louis, MO

Baseline Counseling As usual +1 moreN/ARecruitingLed by Michael J. Durkin, MDResearch Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Admission must be for an infection associated with intravenous drug use

Patient must be willing to speak with healthcare provider about MOUDs

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up12 months

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will test whether an evidence-based method for making treatment decisions, called a "decision aid," can reduce stigma around opioid use disorder (OUD) and increase engagement in treatment among patients and providers in rural Missouri.

Eligible Conditions

Opioid Use Disorder

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You must have an infection caused by using drugs with a needle.

Select...

You must be open to talking with a healthcare provider about medications for opioid use disorder (MOUDs).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of recruitment/randomization

Acceptability of the intervention to patients

Contamination of arms for patients

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Shared Decision Making AidActive Control1 Intervention

Patients randomized to the decision aid arm will receive all of the above as well as a shared decision making aid. This will be a 10-minute tablet- or web-based intervention administered by one of our wraparound care service team members in-person or via telehealth (or possibly in person depending on pandemic procedures). IT will be a 10-minute procedure with summary of decision considerations and patient value assessment.The provider will have access to then have access to this summary in making final care decisions with the patient.

Group II: Baseline Counseling As UsualActive Control1 Intervention

Patients randomized to the baseline counseling as usual arm will receive provision of one of 3 MAT options, prescription and referral to community providers; overdose prevention education and access to naloxone kits; harm reduction counseling (e.g safe injection practices, referral to PrEP); lab testing for HIV, HBV, HCV infection, and routine vaccinations (e.g. Hepatitis A). That includes wrap-around services modeled on the Ryan White Program, with access to social worker, case manager, and mental health counselor who follow up with patients, enroll them in insurance as eligible, and provide ongoing support. This will be a 10-minute tablet- or web-based intervention administered by one of our wraparound care service team members in-person or via telehealth (or possibly in person depending on pandemic procedures). IT will be a 10-minute procedure with summary of decision considerations and patient value assessment.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,900 Previous Clinical Trials

2,280,903 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,397 Previous Clinical Trials

2,060,384 Total Patients Enrolled

Michael J. Durkin, MDPrincipal InvestigatorWashington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity to join this clinical experiment?

"Per the clinicaltrials.gov website, this medical study is still seeking participants. It was first announced on April 7th 2022 and underwent its last update about 3 weeks later on April 26th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Stigma and a Shared Decision Aid

2022. "Stigma and a Shared Decision Aid". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05352412.